Graded review
Glycine for Longevity: The Other Half of GlyNAC
Glycine alone extended mouse lifespan ~6% in the ITP. But the dramatic 'reverses aging' results belong to the GlyNAC combo, not solo glycine. An honest review.
Evidence scorecard
Top of the scorecard
Grade A
CoreAge Rx
Doctor-reviewed longevity peptides and NAD+ with one published per-protocol price and built-in human support.
$93–$99/mo (12-mo plan)
Check availability- Pricing
- Flat monthly, no membership
- Pharmacy
- 503A compounding pharmacy
- Labs
- No labs required
- Consult
- Clinician review included
- Support
- 1:1 nurse + dietitian
Advertising disclosure — we may earn a commission at no extra cost to you. Affiliate partners are listed first on the scorecard.
Also on the scorecard
Grade C
Try Ageless
Every advertised longevity price is an intro-code rate, and the site says outright the real figure arrives after review.
$176–$249/mo list
Visit Try AgelessEvery advertised longevity price is a limited-time intro-code rate: the real list prices are $249 (NAD+ injection) and $176 (sermorelin injection), not the $199 and $126 shown. Compounded and not FDA-approved. Graded on the same rubric as every other provider on our scorecard.
Glycine has an unusual place in the longevity conversation: it's quietly one of the better-evidenced amino acids in animal models, yet most of its fame is borrowed. When people say "glycine reverses aging markers," they're almost always describing GlyNAC — glycine plus N-acetylcysteine — not glycine on its own. Untangling those two is the whole job of this page, because glycine-alone has a real but modest lifespan signal, while the dramatic human-trial headlines belong to the combination. For the wider map of what's earned its place versus what's hype, start with our pillar on longevity medicine: what's proven vs hyped.
What glycine is
Glycine is the smallest amino acid — a single carbon flanked by an amino and a carboxyl group — and it's technically "non-essential" because your body makes it. But "non-essential" is misleading: several lines of evidence suggest endogenous synthesis may fall short of the body's full needs, so glycine is sometimes called conditionally essential. It's abundant in collagen-rich foods (skin, bones, connective tissue, bone broth, gelatin) — which is also why collagen supplements are essentially a glycine-and-proline delivery vehicle once digested — and it does a lot of jobs: it's a building block of glutathione (the cell's master antioxidant), of collagen, and of creatine; it acts as an inhibitory neurotransmitter; and it participates in one-carbon and methionine metabolism. That last role — its tie to methionine and the methylation cycle — turns out to matter for why it might influence aging at all.
The lifespan evidence: a real but modest mouse signal
Here is glycine's strongest single result, and it's worth stating precisely. In the NIA's Interventions Testing Program (ITP) — a rigorous, multi-site mouse-lifespan program designed specifically to weed out the false positives that plague single-lab studies — glycine supplementation extended the lifespan of both male and female mice1. That's a genuinely meaningful finding: the ITP is the gold standard for mouse longevity precisely because it's hard to fool, and relatively few interventions pass it.
But read the size of the effect honestly. The lifespan extension was modest — on the order of a few percent of median lifespan, considerably smaller than ITP standouts like rapamycin. "Statistically real in a rigorous program" and "large" are different things, and glycine's signal is the former, not the latter. The mechanistic story behind it points back to methionine: glycine helps clear methionine, and the benefits of methionine restriction on lifespan are well documented, so part of glycine's effect may be a mild methionine-restriction mimic. That idea is reinforced by invertebrate work showing glycine promotes longevity in C. elegans in a methionine-cycle-dependent fashion2 — different organism, convergent mechanism. Loss of proteostasis and dysregulated nutrient-sensing are catalogued among the formal hallmarks of aging8, and the methionine/one-carbon axis glycine feeds into touches several of them.
Glycine alone vs GlyNAC
| Glycine alone | GlyNAC (glycine + NAC) | |
|---|---|---|
| Lifespan data | Modest ITP mouse extension (~few %); worms | Mouse lifespan result; no solo-glycine human |
| Human data | Sleep + metabolic markers (small, short) | Broad biomarker gains in older adults (24 wk) |
| Endpoints | Surrogate / functional; no longevity trial | Surrogate biomarkers, not lifespan |
| Source of hype | Borrowed from the combo | Single invested research group; not replicated at scale |
The crucial distinction: glycine alone vs GlyNAC
This is the section the marketing blurs, so it deserves to be blunt. The most striking human longevity data attached to "glycine" actually come from GlyNAC — glycine combined with N-acetylcysteine — studied by Rajagopal Sekhar's group at Baylor. Those trials report broad improvements in glutathione, oxidative stress, mitochondrial function, inflammation, and physical performance in older adults6, and the rationale is that aging brings a glutathione deficiency correctable by supplying both missing precursors — glycine and a cysteine donor5. An earlier study in older HIV patients similarly used cysteine and glycine together to raise glutathione and improve insulin sensitivity and body composition7.
Notice the constant: in the dramatic human results, glycine is never alone — it's paired with a cysteine source, because glutathione synthesis needs both. So when a supplement label implies that glycine by itself delivers GlyNAC-style "aging reversal," it's transferring credit the solo amino acid hasn't earned. The honest split is this: glycine alone has a modest, rigorous mouse lifespan signal but no human lifespan or healthspan trial of its own; GlyNAC has small human biomarker trials but is a different intervention, and even those are short-term, surrogate-endpoint studies from a single invested group. We dig into the combination's limits in detail in GlyNAC (glycine + NAC) for aging: what the Baylor trials actually show.
Glycine (alone) by claim
- BExtending lifespan in mice (ITP)Moderate evidence
Real and rigorous, but a modest few-percent effect — far smaller than rapamycin.
- CImproving subjective sleep qualityWeak evidence
Small randomized/controlled studies of ~3 g before bed; near-term, subjective.
- CSupporting glutathione synthesisWeak evidence
Strongest human data pair glycine with a cysteine donor — not glycine alone.
- DSlowing human aging / extending lifespanInsufficient
No human longevity trial of glycine by itself; combo headlines belong to GlyNAC.
What glycine actually does in humans
Strip away the borrowed GlyNAC glory and glycine still has a respectable, if narrow, human evidence base — just not for longevity. A 2024 systematic review in GeroScience of glycine administration across human physiological systems found measurable effects in several domains (metabolic, sleep, vascular) but consistently flagged that the trials are small, heterogeneous, and short, and that longevity or healthspan outcomes simply haven't been tested3.
The single best-characterized near-term human effect is on sleep: small randomized and controlled studies showed that 3 g of glycine before bed improved subjective sleep quality and reduced daytime sleepiness, plausibly via a mild drop in core body temperature4. There's also the glutathione-synthesis role — older adults are relatively glutathione-deficient, and supplying cysteine and glycine restores synthesis and lowers oxidative stress5 — but again, that's the combination story, and it's a biomarker outcome, not a lifespan one. These are real, controlled results, but they're surrogate markers and near-term functional measures in specific contexts, not demonstrations that glycine slows aging or extends life.
Zero human longevity trials for glycine alone
It needs saying plainly: there is no randomized controlled trial showing glycine — by itself — extends human lifespan or healthspan. The lifespan data are from mice1 and worms2; the dramatic human biomarker data belong to GlyNAC, a different intervention67; and glycine's own human trials are about sleep and metabolic markers, not aging34. None of that adds up to "proven to make people age slower." We apply the same mechanism-versus-outcome lens across the field in our best longevity supplements, rated by evidence roundup, and the same single-paper caution in our taurine for longevity review, where one striking amino-acid study outran its evidence.
Safety: the reassuring part
If glycine's longevity efficacy is unproven, its safety story is genuinely reasonable. Glycine is a normal dietary amino acid, abundant in collagen and gelatin, and the doses used in human sleep and metabolic trials (commonly 3–15 g/day) were generally well tolerated, with mild GI upset the most common complaint34. It is sold as a dietary supplement, not an FDA-approved drug for any condition, so it carries no approved indication and no required efficacy proof, and long-term safety of high chronic doses taken specifically for anti-aging hasn't been formally studied. The honest framing is the one this site uses constantly: glycine's safety at studied doses looks acceptable, while its efficacy for longevity in humans is unproven. Those are different claims.
The grade
Longevity Graded verdict
Glycine for longevity: Grade C — modest mouse signal, borrowed human headlines
- Glycine passed the rigorous ITP mouse-lifespan test — but the effect was modest (a few percent).
- Mechanism likely runs through methionine metabolism (a mild methionine-restriction mimic).
- The dramatic human 'aging reversal' results are GlyNAC (glycine + NAC) — a different intervention.
- Solo glycine's real human data are about sleep (~3 g before bed) and glutathione support.
- Zero human longevity trials for glycine alone; safety at studied doses looks reasonable.
- Verdict: a C. Take it for sleep and dietary glutathione support, not as proven anti-aging.
The bottom line
Glycine is better than most longevity amino acids at one thing — passing the rigorous ITP mouse-lifespan test — and worse than the marketing implies at another: its headline human results aren't really its results. The ITP extension was real but modest, the mechanism plausibly runs through methionine metabolism, and the dramatic "aging-marker reversal" trials describe GlyNAC, the glycine-plus-NAC combination, not solo glycine. On its own, glycine has solid near-term human data for sleep and a supporting role in glutathione synthesis, reasonable safety, and zero human longevity trials. If you take glycine, take it for what it's actually supported to do — sleep, a possible mild metabolic nudge, dietary glutathione support — and don't credit it with the combination's biomarker headlines. For where supplements like this fit alongside programs with real clinical oversight, see our graded best longevity clinics hub.
Frequently asked questions
Does glycine extend lifespan?
In mice, modestly. Glycine passed the rigorous NIA Interventions Testing Program — a multi-site mouse-lifespan program designed to filter out false positives — extending lifespan in both sexes, but by only a few percent, far less than interventions like rapamycin. There is no trial showing glycine alone extends lifespan or healthspan in humans. The mechanism may involve mimicking mild methionine restriction.
Is glycine the same as GlyNAC?
No, and this is the key confusion. GlyNAC is glycine combined with N-acetylcysteine (a cysteine donor). The dramatic human 'aging-marker reversal' trials — improvements in glutathione, oxidative stress, mitochondrial function and physical performance in older adults — used the GlyNAC combination, not glycine alone, because glutathione synthesis needs both precursors. Crediting solo glycine with those results overstates what the single amino acid has been shown to do.
What does glycine actually do for humans?
Its best near-term human evidence is for sleep: small randomized and controlled studies found about 3 grams before bed improved subjective sleep quality and reduced daytime sleepiness. A 2024 systematic review found measurable but small, heterogeneous effects across metabolic and vascular systems, and glycine supports glutathione synthesis (best shown alongside a cysteine donor). None of these are longevity outcomes.
Is glycine safe to take?
Glycine is a normal dietary amino acid, abundant in collagen and gelatin, and the doses used in human trials (commonly 3–15 g/day) were generally well tolerated, with mild digestive upset the most common complaint. It's sold as a dietary supplement, not an FDA-approved drug, so it has no approved indication. Safety at studied doses looks reasonable; efficacy for longevity is unproven. This isn't medical advice — check with your clinician, especially if you take other medications.
References
- Miller RA, Harrison DE, Astle CM, et al. (2019). Glycine supplementation extends lifespan of male and female mice.. Aging Cell. https://pubmed.ncbi.nlm.nih.gov/30916479/
- Liu YJ, Janssens GE, McIntyre RL, et al. (2019). Glycine promotes longevity in Caenorhabditis elegans in a methionine cycle-dependent fashion.. PLoS Genetics. https://pubmed.ncbi.nlm.nih.gov/30845140/
- Soh J, Raventhiran S, Lee JH, et al. (2024). The effect of glycine administration on the characteristics of physiological systems in human adults: A systematic review.. GeroScience. https://pubmed.ncbi.nlm.nih.gov/37851316/
- Bannai M, Kawai N (2012). New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep.. Journal of Pharmacological Sciences. https://pubmed.ncbi.nlm.nih.gov/22293292/
- Sekhar RV, Patel SG, Guthikonda AP, et al. (2011). Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation.. American Journal of Clinical Nutrition. https://pubmed.ncbi.nlm.nih.gov/21795440/
- Kumar P, Liu C, Suliburk J, et al. (2023). Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial.. The Journals of Gerontology: Series A. https://pubmed.ncbi.nlm.nih.gov/35975308/
- Nguyen D, Samson SL, Reddy VT, et al. (2014). Effect of increasing glutathione with cysteine and glycine supplementation on mitochondrial fuel oxidation, insulin sensitivity, and body composition in older HIV-infected patients.. Journal of Clinical Endocrinology & Metabolism. https://pubmed.ncbi.nlm.nih.gov/24081740/
- López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G (2023). Hallmarks of aging: An expanding universe.. Cell. https://pubmed.ncbi.nlm.nih.gov/36599349/
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
More graded reviews
Fisetin as a Senolytic: What "Hit-and-Run" Dosing Shows
Fisetin was the standout senolytic flavonoid in mouse screens and extended lifespan ~10%. In humans, the longevity data are essentially zero. An honest review.
ReadGlycine vs GlyNAC: Is Adding NAC Worth It for Longevity?
GlyNAC adds N-acetylcysteine to glycine for glutathione restoration. Is the extra ingredient worth it for longevity? An honest, graded comparison.
ReadAcarbose for Longevity: The Strongest Mouse Drug You've Never Heard Of
Acarbose robustly extended mouse lifespan in the NIA's rigorous ITP — better replicated than most longevity drugs. But there are zero human longevity trials.
ReadDo NAD+ and Peptides Actually Extend Lifespan?
NAD+ precursors reliably raise NAD+ but show modest, mixed human outcomes. Peptides and growth hormone carry real cautions. An honest evidence review.
ReadRapamycin for Longevity: Hype vs Evidence
Rapamycin is the most reproducible lifespan extender in mice — but there is no human longevity trial. An honest split of the hype from the evidence.
ReadGLP-1s for Healthspan & Longevity: The Evidence
GLP-1 drugs have the strongest human outcome data in longevity — but it's cardiometabolic risk reduction, not proven lifespan extension. An honest review.
Read